Katkin Keith Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$541,697.50

Insider Activity of Katkin Keith

According to the SEC Form 4 filings, Katkin Keith, being in a position of

  1. director at Emergent BioSolutions Inc.,
    оver the last 12 months, has bought 0 shares, and sold 15481 share for $128,183,
    over all time since 2025-05-23, has bought 0 shares, and sold 23325 shares for $177,600.

Biography of Katkin Keith

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $128,1831100

Comparison of Insiders on Amount of Buys and Sells

2026-04-30SaleEmergent BioSolutions Inc.
EBS
director
15,481
0.0311%
$8.28$128,183-11.79%
2025-05-23SaleEmergent BioSolutions Inc.
EBS
director
7,844
0.0142%
$6.30$49,417+36.33%
2025-05-19PurchaseSyndax Pharmaceuticals, Inc.
SNDX
director
10,000
0.0114%
$9.11$91,120+83.33%
2022-10-06SaleSyndax Pharmaceuticals, Inc.
SNDX
director
20,782
0.0325%
$25.90$538,273-17.84%
2022-10-04SaleSyndax Pharmaceuticals, Inc.
SNDX
director
137
0.0002%
$25.00$3,425-13.55%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.